nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxorubicin—NOS1—epilepsy syndrome	0.134	0.402	CbGaD
Doxorubicin—RALBP1—Carbamazepine—epilepsy syndrome	0.101	0.282	CbGbCtD
Doxorubicin—NOS2—epilepsy syndrome	0.0706	0.211	CbGaD
Doxorubicin—ABCC2—epilepsy syndrome	0.0469	0.14	CbGaD
Doxorubicin—ABCG2—epilepsy syndrome	0.0414	0.124	CbGaD
Doxorubicin—CYP2D6—epilepsy syndrome	0.0241	0.0721	CbGaD
Doxorubicin—ABCC3—Phenobarbital—epilepsy syndrome	0.0186	0.052	CbGbCtD
Doxorubicin—ABCC2—Levetiracetam—epilepsy syndrome	0.0184	0.0515	CbGbCtD
Doxorubicin—ABCB1—epilepsy syndrome	0.0172	0.0515	CbGaD
Doxorubicin—CYP1B1—Propofol—epilepsy syndrome	0.0168	0.047	CbGbCtD
Doxorubicin—CYP1B1—Phenobarbital—epilepsy syndrome	0.0161	0.045	CbGbCtD
Doxorubicin—ABCB11—Phenobarbital—epilepsy syndrome	0.0161	0.045	CbGbCtD
Doxorubicin—ABCC1—Phenobarbital—epilepsy syndrome	0.0114	0.0319	CbGbCtD
Doxorubicin—ABCC2—Carbamazepine—epilepsy syndrome	0.0106	0.0296	CbGbCtD
Doxorubicin—ABCC2—Phenytoin—epilepsy syndrome	0.0095	0.0265	CbGbCtD
Doxorubicin—CYP2B6—Fosphenytoin—epilepsy syndrome	0.00937	0.0262	CbGbCtD
Doxorubicin—ABCC2—Phenobarbital—epilepsy syndrome	0.00847	0.0236	CbGbCtD
Doxorubicin—CYP2B6—Clobazam—epilepsy syndrome	0.00813	0.0227	CbGbCtD
Doxorubicin—CYP2B6—Carbamazepine—epilepsy syndrome	0.00673	0.0188	CbGbCtD
Doxorubicin—CYP2B6—Primidone—epilepsy syndrome	0.00629	0.0176	CbGbCtD
Doxorubicin—CYP2B6—Phenytoin—epilepsy syndrome	0.00604	0.0169	CbGbCtD
Doxorubicin—ABCB1—Levetiracetam—epilepsy syndrome	0.00601	0.0168	CbGbCtD
Doxorubicin—CYP2B6—Propofol—epilepsy syndrome	0.00563	0.0157	CbGbCtD
Doxorubicin—CYP2B6—Phenobarbital—epilepsy syndrome	0.00538	0.015	CbGbCtD
Doxorubicin—CYP2B6—Midazolam—epilepsy syndrome	0.00531	0.0148	CbGbCtD
Doxorubicin—CYP2B6—Diazepam—epilepsy syndrome	0.0051	0.0143	CbGbCtD
Doxorubicin—ABCB1—Clobazam—epilepsy syndrome	0.00417	0.0116	CbGbCtD
Doxorubicin—CYP2B6—Valproic Acid—epilepsy syndrome	0.00402	0.0112	CbGbCtD
Doxorubicin—ABCB1—Lamotrigine—epilepsy syndrome	0.00401	0.0112	CbGbCtD
Doxorubicin—ABCB1—Carbamazepine—epilepsy syndrome	0.00345	0.00964	CbGbCtD
Doxorubicin—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.00329	0.0092	CbGbCtD
Doxorubicin—ABCB1—Phenytoin—epilepsy syndrome	0.0031	0.00865	CbGbCtD
Doxorubicin—CYP3A4—Felbamate—epilepsy syndrome	0.00306	0.00855	CbGbCtD
Doxorubicin—CYP3A4—Trimethadione—epilepsy syndrome	0.00306	0.00855	CbGbCtD
Doxorubicin—CYP3A4—Fosphenytoin—epilepsy syndrome	0.00288	0.00804	CbGbCtD
Doxorubicin—ABCB1—Phenobarbital—epilepsy syndrome	0.00276	0.00771	CbGbCtD
Doxorubicin—ABCB1—Midazolam—epilepsy syndrome	0.00272	0.0076	CbGbCtD
Doxorubicin—CYP2D6—Propofol—epilepsy syndrome	0.00272	0.0076	CbGbCtD
Doxorubicin—ABCB1—Diazepam—epilepsy syndrome	0.00262	0.00731	CbGbCtD
Doxorubicin—CYP3A4—Clonazepam—epilepsy syndrome	0.0026	0.00727	CbGbCtD
Doxorubicin—CYP3A4—Clobazam—epilepsy syndrome	0.0025	0.00697	CbGbCtD
Doxorubicin—CYP3A4—Rufinamide—epilepsy syndrome	0.00212	0.00593	CbGbCtD
Doxorubicin—CYP3A4—Carbamazepine—epilepsy syndrome	0.00207	0.00578	CbGbCtD
Doxorubicin—ABCB8—ganglion—epilepsy syndrome	0.00197	0.0385	CbGeAlD
Doxorubicin—ABCB8—tongue—epilepsy syndrome	0.00195	0.0381	CbGeAlD
Doxorubicin—CYP3A4—Primidone—epilepsy syndrome	0.00193	0.00539	CbGbCtD
Doxorubicin—CYP3A4—Phenytoin—epilepsy syndrome	0.00186	0.00518	CbGbCtD
Doxorubicin—CYP3A4—Propofol—epilepsy syndrome	0.00173	0.00483	CbGbCtD
Doxorubicin—CYP3A4—Phenobarbital—epilepsy syndrome	0.00165	0.00462	CbGbCtD
Doxorubicin—CYP3A4—Acetazolamide—epilepsy syndrome	0.00165	0.00462	CbGbCtD
Doxorubicin—CYP3A4—Midazolam—epilepsy syndrome	0.00163	0.00455	CbGbCtD
Doxorubicin—CYP3A4—Diazepam—epilepsy syndrome	0.00157	0.00438	CbGbCtD
Doxorubicin—CYP3A4—Zonisamide—epilepsy syndrome	0.00153	0.00427	CbGbCtD
Doxorubicin—CYP3A4—Valproic Acid—epilepsy syndrome	0.00124	0.00345	CbGbCtD
Doxorubicin—CYP3A4—Topiramate—epilepsy syndrome	0.00111	0.00311	CbGbCtD
Doxorubicin—NOS1—ganglion—epilepsy syndrome	0.00111	0.0217	CbGeAlD
Doxorubicin—NDUFS3—ganglion—epilepsy syndrome	0.00109	0.0213	CbGeAlD
Doxorubicin—NOS1—hindbrain—epilepsy syndrome	0.000841	0.0164	CbGeAlD
Doxorubicin—ABCB8—forebrain—epilepsy syndrome	0.000826	0.0161	CbGeAlD
Doxorubicin—NDUFS3—hindbrain—epilepsy syndrome	0.000825	0.0161	CbGeAlD
Doxorubicin—ABCB8—telencephalon—epilepsy syndrome	0.000759	0.0148	CbGeAlD
Doxorubicin—AURKA—Pyrimethamine—Lamotrigine—epilepsy syndrome	0.000745	0.34	CbGdCrCtD
Doxorubicin—NQO1—ganglion—epilepsy syndrome	0.000641	0.0125	CbGeAlD
Doxorubicin—AKR1A1—telencephalon—epilepsy syndrome	0.000564	0.011	CbGeAlD
Doxorubicin—NDUFS7—forebrain—epilepsy syndrome	0.000558	0.0109	CbGeAlD
Doxorubicin—NDUFS7—telencephalon—epilepsy syndrome	0.000513	0.01	CbGeAlD
Doxorubicin—NOS1—brainstem—epilepsy syndrome	0.000482	0.00942	CbGeAlD
Doxorubicin—NDUFS3—brainstem—epilepsy syndrome	0.000473	0.00925	CbGeAlD
Doxorubicin—ABCB8—head—epilepsy syndrome	0.000473	0.00924	CbGeAlD
Doxorubicin—NOS1—forebrain—epilepsy syndrome	0.000465	0.00909	CbGeAlD
Doxorubicin—NDUFS2—forebrain—epilepsy syndrome	0.000462	0.00903	CbGeAlD
Doxorubicin—NDUFS3—forebrain—epilepsy syndrome	0.000456	0.00892	CbGeAlD
Doxorubicin—CBR3—head—epilepsy syndrome	0.000455	0.0089	CbGeAlD
Doxorubicin—ABCB8—nervous system—epilepsy syndrome	0.000448	0.00876	CbGeAlD
Doxorubicin—AKR1A1—medulla oblongata—epilepsy syndrome	0.000443	0.00867	CbGeAlD
Doxorubicin—DHCR7—forebrain—epilepsy syndrome	0.000434	0.00848	CbGeAlD
Doxorubicin—ABCB8—central nervous system—epilepsy syndrome	0.000431	0.00844	CbGeAlD
Doxorubicin—CBR3—nervous system—epilepsy syndrome	0.000431	0.00843	CbGeAlD
Doxorubicin—NOS1—telencephalon—epilepsy syndrome	0.000428	0.00836	CbGeAlD
Doxorubicin—NDUFS2—telencephalon—epilepsy syndrome	0.000425	0.00831	CbGeAlD
Doxorubicin—ABCB8—cerebellum—epilepsy syndrome	0.000422	0.00825	CbGeAlD
Doxorubicin—NDUFS3—telencephalon—epilepsy syndrome	0.00042	0.00821	CbGeAlD
Doxorubicin—CBR3—central nervous system—epilepsy syndrome	0.000415	0.00812	CbGeAlD
Doxorubicin—CBR3—cerebellum—epilepsy syndrome	0.000406	0.00794	CbGeAlD
Doxorubicin—AKR1A1—midbrain—epilepsy syndrome	0.000405	0.00792	CbGeAlD
Doxorubicin—DHCR7—telencephalon—epilepsy syndrome	0.000399	0.0078	CbGeAlD
Doxorubicin—YWHAG—forebrain—epilepsy syndrome	0.000398	0.00778	CbGeAlD
Doxorubicin—AKR1A1—spinal cord—epilepsy syndrome	0.000395	0.00773	CbGeAlD
Doxorubicin—NDUFS7—midbrain—epilepsy syndrome	0.000368	0.0072	CbGeAlD
Doxorubicin—YWHAG—telencephalon—epilepsy syndrome	0.000366	0.00715	CbGeAlD
Doxorubicin—RALBP1—forebrain—epilepsy syndrome	0.000359	0.00703	CbGeAlD
Doxorubicin—NDUFS7—spinal cord—epilepsy syndrome	0.000359	0.00702	CbGeAlD
Doxorubicin—NOS3—forebrain—epilepsy syndrome	0.000354	0.00691	CbGeAlD
Doxorubicin—AKR1A1—head—epilepsy syndrome	0.000351	0.00687	CbGeAlD
Doxorubicin—ABCB8—brain—epilepsy syndrome	0.000343	0.0067	CbGeAlD
Doxorubicin—NOS1—medulla oblongata—epilepsy syndrome	0.000336	0.00657	CbGeAlD
Doxorubicin—CBR1—forebrain—epilepsy syndrome	0.000335	0.00656	CbGeAlD
Doxorubicin—NDUFS2—medulla oblongata—epilepsy syndrome	0.000334	0.00653	CbGeAlD
Doxorubicin—AKR1A1—nervous system—epilepsy syndrome	0.000333	0.00651	CbGeAlD
Doxorubicin—RALBP1—telencephalon—epilepsy syndrome	0.00033	0.00646	CbGeAlD
Doxorubicin—NDUFS3—medulla oblongata—epilepsy syndrome	0.00033	0.00645	CbGeAlD
Doxorubicin—CBR3—brain—epilepsy syndrome	0.00033	0.00645	CbGeAlD
Doxorubicin—Daunorubicin—ABCC2—epilepsy syndrome	0.000325	0.311	CrCbGaD
Doxorubicin—NOS3—telencephalon—epilepsy syndrome	0.000325	0.00636	CbGeAlD
Doxorubicin—AKR1A1—central nervous system—epilepsy syndrome	0.000321	0.00627	CbGeAlD
Doxorubicin—NDUFS7—head—epilepsy syndrome	0.000319	0.00624	CbGeAlD
Doxorubicin—AKR1A1—cerebellum—epilepsy syndrome	0.000313	0.00613	CbGeAlD
Doxorubicin—DHCR7—medulla oblongata—epilepsy syndrome	0.000313	0.00613	CbGeAlD
Doxorubicin—Idarubicin—CYP2D6—epilepsy syndrome	0.000313	0.299	CrCbGaD
Doxorubicin—CBR1—telencephalon—epilepsy syndrome	0.000308	0.00603	CbGeAlD
Doxorubicin—NDUFS2—midbrain—epilepsy syndrome	0.000305	0.00597	CbGeAlD
Doxorubicin—NDUFS7—nervous system—epilepsy syndrome	0.000303	0.00592	CbGeAlD
Doxorubicin—NDUFS3—midbrain—epilepsy syndrome	0.000301	0.00589	CbGeAlD
Doxorubicin—NOS1—spinal cord—epilepsy syndrome	0.0003	0.00586	CbGeAlD
Doxorubicin—NDUFS2—spinal cord—epilepsy syndrome	0.000298	0.00582	CbGeAlD
Doxorubicin—AURKA—head—epilepsy syndrome	0.000297	0.0058	CbGeAlD
Doxorubicin—NDUFS3—spinal cord—epilepsy syndrome	0.000294	0.00575	CbGeAlD
Doxorubicin—NDUFS7—central nervous system—epilepsy syndrome	0.000291	0.0057	CbGeAlD
Doxorubicin—Daunorubicin—ABCG2—epilepsy syndrome	0.000288	0.275	CrCbGaD
Doxorubicin—YWHAG—medulla oblongata—epilepsy syndrome	0.000287	0.00562	CbGeAlD
Doxorubicin—DHCR7—midbrain—epilepsy syndrome	0.000286	0.0056	CbGeAlD
Doxorubicin—NDUFS7—cerebellum—epilepsy syndrome	0.000285	0.00557	CbGeAlD
Doxorubicin—TOP2A—Pyrimethamine—Lamotrigine—epilepsy syndrome	0.000285	0.13	CbGdCrCtD
Doxorubicin—AURKA—nervous system—epilepsy syndrome	0.000281	0.0055	CbGeAlD
Doxorubicin—DHCR7—spinal cord—epilepsy syndrome	0.000279	0.00546	CbGeAlD
Doxorubicin—AURKA—central nervous system—epilepsy syndrome	0.000271	0.0053	CbGeAlD
Doxorubicin—NQO1—forebrain—epilepsy syndrome	0.000269	0.00526	CbGeAlD
Doxorubicin—NOS1—head—epilepsy syndrome	0.000266	0.00521	CbGeAlD
Doxorubicin—NDUFS2—head—epilepsy syndrome	0.000265	0.00517	CbGeAlD
Doxorubicin—YWHAG—midbrain—epilepsy syndrome	0.000263	0.00514	CbGeAlD
Doxorubicin—NDUFS3—head—epilepsy syndrome	0.000261	0.00511	CbGeAlD
Doxorubicin—RALBP1—medulla oblongata—epilepsy syndrome	0.00026	0.00508	CbGeAlD
Doxorubicin—YWHAG—spinal cord—epilepsy syndrome	0.000256	0.00501	CbGeAlD
Doxorubicin—AKR1A1—brain—epilepsy syndrome	0.000255	0.00498	CbGeAlD
Doxorubicin—NOS1—nervous system—epilepsy syndrome	0.000252	0.00494	CbGeAlD
Doxorubicin—NDUFS2—nervous system—epilepsy syndrome	0.000251	0.0049	CbGeAlD
Doxorubicin—DHCR7—head—epilepsy syndrome	0.000248	0.00485	CbGeAlD
Doxorubicin—NDUFS3—nervous system—epilepsy syndrome	0.000248	0.00484	CbGeAlD
Doxorubicin—NQO1—telencephalon—epilepsy syndrome	0.000247	0.00483	CbGeAlD
Doxorubicin—NOS1—central nervous system—epilepsy syndrome	0.000243	0.00475	CbGeAlD
Doxorubicin—CBR1—medulla oblongata—epilepsy syndrome	0.000242	0.00474	CbGeAlD
Doxorubicin—ABCC6—head—epilepsy syndrome	0.000242	0.00473	CbGeAlD
Doxorubicin—NDUFS2—central nervous system—epilepsy syndrome	0.000241	0.00472	CbGeAlD
Doxorubicin—AKR1C3—medulla oblongata—epilepsy syndrome	0.000239	0.00468	CbGeAlD
Doxorubicin—NDUFS3—central nervous system—epilepsy syndrome	0.000239	0.00466	CbGeAlD
Doxorubicin—NOS1—cerebellum—epilepsy syndrome	0.000238	0.00464	CbGeAlD
Doxorubicin—RALBP1—midbrain—epilepsy syndrome	0.000237	0.00464	CbGeAlD
Doxorubicin—NDUFS2—cerebellum—epilepsy syndrome	0.000236	0.00462	CbGeAlD
Doxorubicin—DHCR7—nervous system—epilepsy syndrome	0.000235	0.0046	CbGeAlD
Doxorubicin—NDUFS3—cerebellum—epilepsy syndrome	0.000233	0.00456	CbGeAlD
Doxorubicin—RALBP1—spinal cord—epilepsy syndrome	0.000232	0.00453	CbGeAlD
Doxorubicin—NDUFS7—brain—epilepsy syndrome	0.000231	0.00452	CbGeAlD
Doxorubicin—YWHAG—head—epilepsy syndrome	0.000228	0.00445	CbGeAlD
Doxorubicin—DHCR7—central nervous system—epilepsy syndrome	0.000227	0.00443	CbGeAlD
Doxorubicin—DHCR7—cerebellum—epilepsy syndrome	0.000222	0.00433	CbGeAlD
Doxorubicin—CBR1—midbrain—epilepsy syndrome	0.000222	0.00433	CbGeAlD
Doxorubicin—ABCC10—telencephalon—epilepsy syndrome	0.000221	0.00432	CbGeAlD
Doxorubicin—AKR1C3—midbrain—epilepsy syndrome	0.000219	0.00428	CbGeAlD
Doxorubicin—POR—medulla oblongata—epilepsy syndrome	0.000219	0.00427	CbGeAlD
Doxorubicin—CBR1—spinal cord—epilepsy syndrome	0.000216	0.00423	CbGeAlD
Doxorubicin—YWHAG—nervous system—epilepsy syndrome	0.000216	0.00422	CbGeAlD
Doxorubicin—AURKA—brain—epilepsy syndrome	0.000215	0.00421	CbGeAlD
Doxorubicin—AKR1C3—spinal cord—epilepsy syndrome	0.000213	0.00417	CbGeAlD
Doxorubicin—YWHAG—central nervous system—epilepsy syndrome	0.000208	0.00407	CbGeAlD
Doxorubicin—RALBP1—head—epilepsy syndrome	0.000206	0.00402	CbGeAlD
Doxorubicin—YWHAG—cerebellum—epilepsy syndrome	0.000203	0.00397	CbGeAlD
Doxorubicin—NOS3—head—epilepsy syndrome	0.000202	0.00396	CbGeAlD
Doxorubicin—POR—midbrain—epilepsy syndrome	0.0002	0.00391	CbGeAlD
Doxorubicin—RALBP1—nervous system—epilepsy syndrome	0.000195	0.00381	CbGeAlD
Doxorubicin—POR—spinal cord—epilepsy syndrome	0.000195	0.00381	CbGeAlD
Doxorubicin—NQO1—medulla oblongata—epilepsy syndrome	0.000194	0.0038	CbGeAlD
Doxorubicin—NOS1—brain—epilepsy syndrome	0.000193	0.00377	CbGeAlD
Doxorubicin—CBR1—head—epilepsy syndrome	0.000192	0.00376	CbGeAlD
Doxorubicin—NOS3—nervous system—epilepsy syndrome	0.000192	0.00375	CbGeAlD
Doxorubicin—NDUFS2—brain—epilepsy syndrome	0.000192	0.00375	CbGeAlD
Doxorubicin—NDUFS3—brain—epilepsy syndrome	0.000189	0.0037	CbGeAlD
Doxorubicin—RALBP1—central nervous system—epilepsy syndrome	0.000188	0.00367	CbGeAlD
Doxorubicin—NOS3—central nervous system—epilepsy syndrome	0.000185	0.00361	CbGeAlD
Doxorubicin—RALBP1—cerebellum—epilepsy syndrome	0.000184	0.00359	CbGeAlD
Doxorubicin—CBR3—Alprazolam—Clonazepam—epilepsy syndrome	0.000183	0.0837	CbGdCrCtD
Doxorubicin—CBR1—nervous system—epilepsy syndrome	0.000182	0.00356	CbGeAlD
Doxorubicin—DHCR7—brain—epilepsy syndrome	0.00018	0.00352	CbGeAlD
Doxorubicin—NQO1—midbrain—epilepsy syndrome	0.000177	0.00347	CbGeAlD
Doxorubicin—CBR1—central nervous system—epilepsy syndrome	0.000175	0.00343	CbGeAlD
Doxorubicin—CBR3—Alprazolam—Midazolam—epilepsy syndrome	0.000175	0.0798	CbGdCrCtD
Doxorubicin—CYP2D6—hindbrain—epilepsy syndrome	0.000174	0.00341	CbGeAlD
Doxorubicin—CYP1B1—telencephalon—epilepsy syndrome	0.000174	0.00339	CbGeAlD
Doxorubicin—ABCC10—medulla oblongata—epilepsy syndrome	0.000173	0.00339	CbGeAlD
Doxorubicin—NQO1—spinal cord—epilepsy syndrome	0.000173	0.00339	CbGeAlD
Doxorubicin—CBR1—cerebellum—epilepsy syndrome	0.000171	0.00335	CbGeAlD
Doxorubicin—AKR1C3—cerebellum—epilepsy syndrome	0.000169	0.00331	CbGeAlD
Doxorubicin—CBR3—Alprazolam—Clobazam—epilepsy syndrome	0.000167	0.0765	CbGdCrCtD
Doxorubicin—YWHAG—brain—epilepsy syndrome	0.000165	0.00323	CbGeAlD
Doxorubicin—ABCC10—midbrain—epilepsy syndrome	0.000159	0.0031	CbGeAlD
Doxorubicin—ABCC1—telencephalon—epilepsy syndrome	0.000156	0.00305	CbGeAlD
Doxorubicin—CBR3—Alprazolam—Diazepam—epilepsy syndrome	0.000156	0.0711	CbGdCrCtD
Doxorubicin—ABCC10—spinal cord—epilepsy syndrome	0.000155	0.00302	CbGeAlD
Doxorubicin—POR—cerebellum—epilepsy syndrome	0.000155	0.00302	CbGeAlD
Doxorubicin—NQO1—head—epilepsy syndrome	0.000154	0.00301	CbGeAlD
Doxorubicin—RALBP1—brain—epilepsy syndrome	0.000149	0.00292	CbGeAlD
Doxorubicin—NOS3—brain—epilepsy syndrome	0.000147	0.00287	CbGeAlD
Doxorubicin—NQO1—nervous system—epilepsy syndrome	0.000146	0.00285	CbGeAlD
Doxorubicin—NQO1—central nervous system—epilepsy syndrome	0.00014	0.00275	CbGeAlD
Doxorubicin—CBR1—brain—epilepsy syndrome	0.000139	0.00272	CbGeAlD
Doxorubicin—ABCC3—head—epilepsy syndrome	0.000138	0.0027	CbGeAlD
Doxorubicin—AKR1C3—brain—epilepsy syndrome	0.000137	0.00269	CbGeAlD
Doxorubicin—NQO1—cerebellum—epilepsy syndrome	0.000137	0.00268	CbGeAlD
Doxorubicin—ABCC3—nervous system—epilepsy syndrome	0.000131	0.00256	CbGeAlD
Doxorubicin—CBR3—Niclosamide—Clonazepam—epilepsy syndrome	0.000129	0.0591	CbGdCrCtD
Doxorubicin—ABCG2—telencephalon—epilepsy syndrome	0.000129	0.00253	CbGeAlD
Doxorubicin—ABCC3—central nervous system—epilepsy syndrome	0.000126	0.00247	CbGeAlD
Doxorubicin—POR—brain—epilepsy syndrome	0.000126	0.00245	CbGeAlD
Doxorubicin—ABCC10—cerebellum—epilepsy syndrome	0.000123	0.0024	CbGeAlD
Doxorubicin—Daunorubicin—ABCB1—epilepsy syndrome	0.00012	0.115	CrCbGaD
Doxorubicin—NQO1—brain—epilepsy syndrome	0.000112	0.00218	CbGeAlD
Doxorubicin—CYP1B1—head—epilepsy syndrome	0.000108	0.00211	CbGeAlD
Doxorubicin—CYP1B1—nervous system—epilepsy syndrome	0.000102	0.002	CbGeAlD
Doxorubicin—ABCG2—medulla oblongata—epilepsy syndrome	0.000102	0.00199	CbGeAlD
Doxorubicin—ABCC3—brain—epilepsy syndrome	0.0001	0.00196	CbGeAlD
Doxorubicin—CYP2D6—brainstem—epilepsy syndrome	9.98e-05	0.00195	CbGeAlD
Doxorubicin—ABCC10—brain—epilepsy syndrome	9.96e-05	0.00195	CbGeAlD
Doxorubicin—CYP1B1—central nervous system—epilepsy syndrome	9.87e-05	0.00193	CbGeAlD
Doxorubicin—AURKA—Bortezomib—Lacosamide—epilepsy syndrome	9.84e-05	0.045	CbGdCrCtD
Doxorubicin—CYP1B1—cerebellum—epilepsy syndrome	9.64e-05	0.00189	CbGeAlD
Doxorubicin—CYP2D6—forebrain—epilepsy syndrome	9.64e-05	0.00188	CbGeAlD
Doxorubicin—CBR1—Niclosamide—Clonazepam—epilepsy syndrome	9.59e-05	0.0438	CbGdCrCtD
Doxorubicin—ABCG2—midbrain—epilepsy syndrome	9.28e-05	0.00181	CbGeAlD
Doxorubicin—ABCG2—spinal cord—epilepsy syndrome	9.06e-05	0.00177	CbGeAlD
Doxorubicin—CYP2D6—telencephalon—epilepsy syndrome	8.86e-05	0.00173	CbGeAlD
Doxorubicin—ABCC1—cerebellum—epilepsy syndrome	8.67e-05	0.0017	CbGeAlD
Doxorubicin—CYP1B1—brain—epilepsy syndrome	7.83e-05	0.00153	CbGeAlD
Doxorubicin—CYP2B6—head—epilepsy syndrome	7.42e-05	0.00145	CbGeAlD
Doxorubicin—ABCG2—cerebellum—epilepsy syndrome	7.18e-05	0.0014	CbGeAlD
Doxorubicin—ABCC1—brain—epilepsy syndrome	7.04e-05	0.00138	CbGeAlD
Doxorubicin—CYP2B6—nervous system—epilepsy syndrome	7.04e-05	0.00138	CbGeAlD
Doxorubicin—ABCB1—forebrain—epilepsy syndrome	6.93e-05	0.00136	CbGeAlD
Doxorubicin—AURKA—Niclosamide—Clonazepam—epilepsy syndrome	6.82e-05	0.0312	CbGdCrCtD
Doxorubicin—CYP2B6—central nervous system—epilepsy syndrome	6.78e-05	0.00133	CbGeAlD
Doxorubicin—ABCB1—telencephalon—epilepsy syndrome	6.37e-05	0.00125	CbGeAlD
Doxorubicin—ABCG2—brain—epilepsy syndrome	5.83e-05	0.00114	CbGeAlD
Doxorubicin—CYP2D6—head—epilepsy syndrome	5.52e-05	0.00108	CbGeAlD
Doxorubicin—CYP2B6—brain—epilepsy syndrome	5.38e-05	0.00105	CbGeAlD
Doxorubicin—CYP3A4—nervous system—epilepsy syndrome	5.32e-05	0.00104	CbGeAlD
Doxorubicin—CYP2D6—nervous system—epilepsy syndrome	5.23e-05	0.00102	CbGeAlD
Doxorubicin—CYP3A4—central nervous system—epilepsy syndrome	5.12e-05	0.001	CbGeAlD
Doxorubicin—CYP2D6—central nervous system—epilepsy syndrome	5.04e-05	0.000985	CbGeAlD
Doxorubicin—ABCB1—medulla oblongata—epilepsy syndrome	5.01e-05	0.000979	CbGeAlD
Doxorubicin—CYP2D6—cerebellum—epilepsy syndrome	4.92e-05	0.000962	CbGeAlD
Doxorubicin—ABCB1—midbrain—epilepsy syndrome	4.58e-05	0.000895	CbGeAlD
Doxorubicin—ABCB1—spinal cord—epilepsy syndrome	4.47e-05	0.000873	CbGeAlD
Doxorubicin—CYP2D6—brain—epilepsy syndrome	4e-05	0.000782	CbGeAlD
Doxorubicin—ABCB1—head—epilepsy syndrome	3.97e-05	0.000776	CbGeAlD
Doxorubicin—ABCB1—nervous system—epilepsy syndrome	3.76e-05	0.000736	CbGeAlD
Doxorubicin—TOP2A—Bortezomib—Lacosamide—epilepsy syndrome	3.76e-05	0.0172	CbGdCrCtD
Doxorubicin—ABCB1—central nervous system—epilepsy syndrome	3.62e-05	0.000708	CbGeAlD
Doxorubicin—ABCB1—cerebellum—epilepsy syndrome	3.54e-05	0.000692	CbGeAlD
Doxorubicin—ABCB1—brain—epilepsy syndrome	2.88e-05	0.000562	CbGeAlD
Doxorubicin—TOP2A—Niclosamide—Clonazepam—epilepsy syndrome	2.61e-05	0.0119	CbGdCrCtD
Doxorubicin—TOP2A—Chlorpromazine—Clobazam—epilepsy syndrome	2.23e-05	0.0102	CbGdCrCtD
Doxorubicin—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	1.46e-05	9.1e-05	CcSEcCtD
Doxorubicin—Hypotension—Valproic Acid—epilepsy syndrome	1.46e-05	9.07e-05	CcSEcCtD
Doxorubicin—Asthenia—Carbamazepine—epilepsy syndrome	1.46e-05	9.07e-05	CcSEcCtD
Doxorubicin—Agitation—Gabapentin—epilepsy syndrome	1.46e-05	9.07e-05	CcSEcCtD
Doxorubicin—Diarrhoea—Phenytoin—epilepsy syndrome	1.46e-05	9.06e-05	CcSEcCtD
Doxorubicin—Discomfort—Pregabalin—epilepsy syndrome	1.45e-05	9.05e-05	CcSEcCtD
Doxorubicin—Nausea—Fosphenytoin—epilepsy syndrome	1.45e-05	9.04e-05	CcSEcCtD
Doxorubicin—Diarrhoea—Oxcarbazepine—epilepsy syndrome	1.45e-05	9.02e-05	CcSEcCtD
Doxorubicin—Erythema multiforme—Topiramate—epilepsy syndrome	1.45e-05	9.01e-05	CcSEcCtD
Doxorubicin—Hypersensitivity—Lamotrigine—epilepsy syndrome	1.45e-05	9e-05	CcSEcCtD
Doxorubicin—Vomiting—Felbamate—epilepsy syndrome	1.44e-05	8.99e-05	CcSEcCtD
Doxorubicin—Dry mouth—Pregabalin—epilepsy syndrome	1.44e-05	8.96e-05	CcSEcCtD
Doxorubicin—Pruritus—Carbamazepine—epilepsy syndrome	1.44e-05	8.95e-05	CcSEcCtD
Doxorubicin—Rash—Felbamate—epilepsy syndrome	1.43e-05	8.91e-05	CcSEcCtD
Doxorubicin—Eye disorder—Topiramate—epilepsy syndrome	1.43e-05	8.91e-05	CcSEcCtD
Doxorubicin—Dermatitis—Felbamate—epilepsy syndrome	1.43e-05	8.91e-05	CcSEcCtD
Doxorubicin—Malaise—Gabapentin—epilepsy syndrome	1.43e-05	8.9e-05	CcSEcCtD
Doxorubicin—Tinnitus—Topiramate—epilepsy syndrome	1.43e-05	8.89e-05	CcSEcCtD
Doxorubicin—Vertigo—Gabapentin—epilepsy syndrome	1.42e-05	8.86e-05	CcSEcCtD
Doxorubicin—Headache—Felbamate—epilepsy syndrome	1.42e-05	8.86e-05	CcSEcCtD
Doxorubicin—Confusional state—Pregabalin—epilepsy syndrome	1.42e-05	8.85e-05	CcSEcCtD
Doxorubicin—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	1.42e-05	8.85e-05	CcSEcCtD
Doxorubicin—Flushing—Topiramate—epilepsy syndrome	1.42e-05	8.85e-05	CcSEcCtD
Doxorubicin—Cardiac disorder—Topiramate—epilepsy syndrome	1.42e-05	8.85e-05	CcSEcCtD
Doxorubicin—Syncope—Gabapentin—epilepsy syndrome	1.42e-05	8.85e-05	CcSEcCtD
Doxorubicin—Leukopenia—Gabapentin—epilepsy syndrome	1.42e-05	8.83e-05	CcSEcCtD
Doxorubicin—Dizziness—Clonazepam—epilepsy syndrome	1.42e-05	8.82e-05	CcSEcCtD
Doxorubicin—Nausea—Vigabatrin—epilepsy syndrome	1.42e-05	8.81e-05	CcSEcCtD
Doxorubicin—Vomiting—Zonisamide—epilepsy syndrome	1.41e-05	8.8e-05	CcSEcCtD
Doxorubicin—Insomnia—Valproic Acid—epilepsy syndrome	1.41e-05	8.78e-05	CcSEcCtD
Doxorubicin—Anaphylactic shock—Pregabalin—epilepsy syndrome	1.41e-05	8.78e-05	CcSEcCtD
Doxorubicin—Oedema—Pregabalin—epilepsy syndrome	1.41e-05	8.78e-05	CcSEcCtD
Doxorubicin—Asthenia—Lamotrigine—epilepsy syndrome	1.41e-05	8.77e-05	CcSEcCtD
Doxorubicin—Dizziness—Phenytoin—epilepsy syndrome	1.41e-05	8.76e-05	CcSEcCtD
Doxorubicin—Rash—Zonisamide—epilepsy syndrome	1.4e-05	8.73e-05	CcSEcCtD
Doxorubicin—Infection—Pregabalin—epilepsy syndrome	1.4e-05	8.72e-05	CcSEcCtD
Doxorubicin—Paraesthesia—Valproic Acid—epilepsy syndrome	1.4e-05	8.72e-05	CcSEcCtD
Doxorubicin—Palpitations—Gabapentin—epilepsy syndrome	1.4e-05	8.72e-05	CcSEcCtD
Doxorubicin—Dermatitis—Zonisamide—epilepsy syndrome	1.4e-05	8.72e-05	CcSEcCtD
Doxorubicin—Dizziness—Oxcarbazepine—epilepsy syndrome	1.4e-05	8.71e-05	CcSEcCtD
Doxorubicin—Nausea—Diazepam—epilepsy syndrome	1.39e-05	8.68e-05	CcSEcCtD
Doxorubicin—Loss of consciousness—Gabapentin—epilepsy syndrome	1.39e-05	8.67e-05	CcSEcCtD
Doxorubicin—Headache—Zonisamide—epilepsy syndrome	1.39e-05	8.67e-05	CcSEcCtD
Doxorubicin—Dyspnoea—Valproic Acid—epilepsy syndrome	1.39e-05	8.66e-05	CcSEcCtD
Doxorubicin—Diarrhoea—Carbamazepine—epilepsy syndrome	1.39e-05	8.65e-05	CcSEcCtD
Doxorubicin—Angiopathy—Topiramate—epilepsy syndrome	1.39e-05	8.65e-05	CcSEcCtD
Doxorubicin—Pruritus—Lamotrigine—epilepsy syndrome	1.39e-05	8.65e-05	CcSEcCtD
Doxorubicin—Shock—Pregabalin—epilepsy syndrome	1.39e-05	8.64e-05	CcSEcCtD
Doxorubicin—Somnolence—Valproic Acid—epilepsy syndrome	1.39e-05	8.63e-05	CcSEcCtD
Doxorubicin—Immune system disorder—Topiramate—epilepsy syndrome	1.38e-05	8.61e-05	CcSEcCtD
Doxorubicin—Nervous system disorder—Pregabalin—epilepsy syndrome	1.38e-05	8.61e-05	CcSEcCtD
Doxorubicin—Cough—Gabapentin—epilepsy syndrome	1.38e-05	8.61e-05	CcSEcCtD
Doxorubicin—Thrombocytopenia—Pregabalin—epilepsy syndrome	1.38e-05	8.6e-05	CcSEcCtD
Doxorubicin—Mediastinal disorder—Topiramate—epilepsy syndrome	1.38e-05	8.59e-05	CcSEcCtD
Doxorubicin—Tachycardia—Pregabalin—epilepsy syndrome	1.38e-05	8.57e-05	CcSEcCtD
Doxorubicin—Chills—Topiramate—epilepsy syndrome	1.37e-05	8.55e-05	CcSEcCtD
Doxorubicin—Dyspepsia—Valproic Acid—epilepsy syndrome	1.37e-05	8.55e-05	CcSEcCtD
Doxorubicin—Convulsion—Gabapentin—epilepsy syndrome	1.37e-05	8.55e-05	CcSEcCtD
Doxorubicin—Skin disorder—Pregabalin—epilepsy syndrome	1.37e-05	8.53e-05	CcSEcCtD
Doxorubicin—Hypertension—Gabapentin—epilepsy syndrome	1.37e-05	8.52e-05	CcSEcCtD
Doxorubicin—Hyperhidrosis—Pregabalin—epilepsy syndrome	1.36e-05	8.49e-05	CcSEcCtD
Doxorubicin—Vomiting—Clonazepam—epilepsy syndrome	1.36e-05	8.48e-05	CcSEcCtD
Doxorubicin—Decreased appetite—Valproic Acid—epilepsy syndrome	1.36e-05	8.44e-05	CcSEcCtD
Doxorubicin—Alopecia—Topiramate—epilepsy syndrome	1.35e-05	8.42e-05	CcSEcCtD
Doxorubicin—Vomiting—Phenytoin—epilepsy syndrome	1.35e-05	8.42e-05	CcSEcCtD
Doxorubicin—Rash—Clonazepam—epilepsy syndrome	1.35e-05	8.41e-05	CcSEcCtD
Doxorubicin—Dermatitis—Clonazepam—epilepsy syndrome	1.35e-05	8.4e-05	CcSEcCtD
Doxorubicin—Myalgia—Gabapentin—epilepsy syndrome	1.35e-05	8.4e-05	CcSEcCtD
Doxorubicin—Chest pain—Gabapentin—epilepsy syndrome	1.35e-05	8.4e-05	CcSEcCtD
Doxorubicin—Arthralgia—Gabapentin—epilepsy syndrome	1.35e-05	8.4e-05	CcSEcCtD
Doxorubicin—Nausea—Felbamate—epilepsy syndrome	1.35e-05	8.4e-05	CcSEcCtD
Doxorubicin—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	1.35e-05	8.38e-05	CcSEcCtD
Doxorubicin—Vomiting—Oxcarbazepine—epilepsy syndrome	1.35e-05	8.38e-05	CcSEcCtD
Doxorubicin—Fatigue—Valproic Acid—epilepsy syndrome	1.35e-05	8.37e-05	CcSEcCtD
Doxorubicin—Anxiety—Gabapentin—epilepsy syndrome	1.34e-05	8.37e-05	CcSEcCtD
Doxorubicin—Anorexia—Pregabalin—epilepsy syndrome	1.34e-05	8.37e-05	CcSEcCtD
Doxorubicin—Dizziness—Carbamazepine—epilepsy syndrome	1.34e-05	8.36e-05	CcSEcCtD
Doxorubicin—Diarrhoea—Lamotrigine—epilepsy syndrome	1.34e-05	8.36e-05	CcSEcCtD
Doxorubicin—Headache—Clonazepam—epilepsy syndrome	1.34e-05	8.35e-05	CcSEcCtD
Doxorubicin—Rash—Phenytoin—epilepsy syndrome	1.34e-05	8.35e-05	CcSEcCtD
Doxorubicin—Mental disorder—Topiramate—epilepsy syndrome	1.34e-05	8.35e-05	CcSEcCtD
Doxorubicin—Dermatitis—Phenytoin—epilepsy syndrome	1.34e-05	8.34e-05	CcSEcCtD
Doxorubicin—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	1.34e-05	8.34e-05	CcSEcCtD
Doxorubicin—Rash—Oxcarbazepine—epilepsy syndrome	1.34e-05	8.31e-05	CcSEcCtD
Doxorubicin—Pain—Valproic Acid—epilepsy syndrome	1.33e-05	8.3e-05	CcSEcCtD
Doxorubicin—Constipation—Valproic Acid—epilepsy syndrome	1.33e-05	8.3e-05	CcSEcCtD
Doxorubicin—Dermatitis—Oxcarbazepine—epilepsy syndrome	1.33e-05	8.3e-05	CcSEcCtD
Doxorubicin—Headache—Phenytoin—epilepsy syndrome	1.33e-05	8.3e-05	CcSEcCtD
Doxorubicin—Malnutrition—Topiramate—epilepsy syndrome	1.33e-05	8.3e-05	CcSEcCtD
Doxorubicin—Erythema—Topiramate—epilepsy syndrome	1.33e-05	8.3e-05	CcSEcCtD
Doxorubicin—Discomfort—Gabapentin—epilepsy syndrome	1.33e-05	8.3e-05	CcSEcCtD
Doxorubicin—Headache—Oxcarbazepine—epilepsy syndrome	1.33e-05	8.26e-05	CcSEcCtD
Doxorubicin—Nausea—Zonisamide—epilepsy syndrome	1.32e-05	8.22e-05	CcSEcCtD
Doxorubicin—Dry mouth—Gabapentin—epilepsy syndrome	1.32e-05	8.21e-05	CcSEcCtD
Doxorubicin—Hypotension—Pregabalin—epilepsy syndrome	1.32e-05	8.2e-05	CcSEcCtD
Doxorubicin—Flatulence—Topiramate—epilepsy syndrome	1.31e-05	8.18e-05	CcSEcCtD
Doxorubicin—Tension—Topiramate—epilepsy syndrome	1.31e-05	8.14e-05	CcSEcCtD
Doxorubicin—Dysgeusia—Topiramate—epilepsy syndrome	1.31e-05	8.13e-05	CcSEcCtD
Doxorubicin—Confusional state—Gabapentin—epilepsy syndrome	1.3e-05	8.12e-05	CcSEcCtD
Doxorubicin—Dizziness—Lamotrigine—epilepsy syndrome	1.3e-05	8.08e-05	CcSEcCtD
Doxorubicin—Nervousness—Topiramate—epilepsy syndrome	1.3e-05	8.06e-05	CcSEcCtD
Doxorubicin—Oedema—Gabapentin—epilepsy syndrome	1.29e-05	8.05e-05	CcSEcCtD
Doxorubicin—Anaphylactic shock—Gabapentin—epilepsy syndrome	1.29e-05	8.05e-05	CcSEcCtD
Doxorubicin—Vomiting—Carbamazepine—epilepsy syndrome	1.29e-05	8.04e-05	CcSEcCtD
Doxorubicin—Back pain—Topiramate—epilepsy syndrome	1.29e-05	8.03e-05	CcSEcCtD
Doxorubicin—Feeling abnormal—Valproic Acid—epilepsy syndrome	1.29e-05	8e-05	CcSEcCtD
Doxorubicin—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	1.29e-05	8e-05	CcSEcCtD
Doxorubicin—Infection—Gabapentin—epilepsy syndrome	1.29e-05	8e-05	CcSEcCtD
Doxorubicin—Muscle spasms—Topiramate—epilepsy syndrome	1.28e-05	7.98e-05	CcSEcCtD
Doxorubicin—Rash—Carbamazepine—epilepsy syndrome	1.28e-05	7.97e-05	CcSEcCtD
Doxorubicin—Dermatitis—Carbamazepine—epilepsy syndrome	1.28e-05	7.97e-05	CcSEcCtD
Doxorubicin—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	1.28e-05	7.94e-05	CcSEcCtD
Doxorubicin—Insomnia—Pregabalin—epilepsy syndrome	1.28e-05	7.94e-05	CcSEcCtD
Doxorubicin—Nausea—Clonazepam—epilepsy syndrome	1.27e-05	7.92e-05	CcSEcCtD
Doxorubicin—Headache—Carbamazepine—epilepsy syndrome	1.27e-05	7.92e-05	CcSEcCtD
Doxorubicin—Shock—Gabapentin—epilepsy syndrome	1.27e-05	7.92e-05	CcSEcCtD
Doxorubicin—Nervous system disorder—Gabapentin—epilepsy syndrome	1.27e-05	7.9e-05	CcSEcCtD
Doxorubicin—Paraesthesia—Pregabalin—epilepsy syndrome	1.27e-05	7.88e-05	CcSEcCtD
Doxorubicin—Thrombocytopenia—Gabapentin—epilepsy syndrome	1.27e-05	7.88e-05	CcSEcCtD
Doxorubicin—Nausea—Phenytoin—epilepsy syndrome	1.26e-05	7.87e-05	CcSEcCtD
Doxorubicin—Tachycardia—Gabapentin—epilepsy syndrome	1.26e-05	7.86e-05	CcSEcCtD
Doxorubicin—Dyspnoea—Pregabalin—epilepsy syndrome	1.26e-05	7.83e-05	CcSEcCtD
Doxorubicin—Nausea—Oxcarbazepine—epilepsy syndrome	1.26e-05	7.83e-05	CcSEcCtD
Doxorubicin—Vision blurred—Topiramate—epilepsy syndrome	1.26e-05	7.82e-05	CcSEcCtD
Doxorubicin—Skin disorder—Gabapentin—epilepsy syndrome	1.26e-05	7.82e-05	CcSEcCtD
Doxorubicin—Somnolence—Pregabalin—epilepsy syndrome	1.25e-05	7.81e-05	CcSEcCtD
Doxorubicin—Hyperhidrosis—Gabapentin—epilepsy syndrome	1.25e-05	7.78e-05	CcSEcCtD
Doxorubicin—Vomiting—Lamotrigine—epilepsy syndrome	1.25e-05	7.77e-05	CcSEcCtD
Doxorubicin—Urticaria—Valproic Acid—epilepsy syndrome	1.24e-05	7.71e-05	CcSEcCtD
Doxorubicin—Rash—Lamotrigine—epilepsy syndrome	1.24e-05	7.71e-05	CcSEcCtD
Doxorubicin—Ill-defined disorder—Topiramate—epilepsy syndrome	1.24e-05	7.7e-05	CcSEcCtD
Doxorubicin—Dermatitis—Lamotrigine—epilepsy syndrome	1.24e-05	7.7e-05	CcSEcCtD
Doxorubicin—Abdominal pain—Valproic Acid—epilepsy syndrome	1.23e-05	7.68e-05	CcSEcCtD
Doxorubicin—Body temperature increased—Valproic Acid—epilepsy syndrome	1.23e-05	7.68e-05	CcSEcCtD
Doxorubicin—Anorexia—Gabapentin—epilepsy syndrome	1.23e-05	7.67e-05	CcSEcCtD
Doxorubicin—Anaemia—Topiramate—epilepsy syndrome	1.23e-05	7.67e-05	CcSEcCtD
Doxorubicin—Headache—Lamotrigine—epilepsy syndrome	1.23e-05	7.66e-05	CcSEcCtD
Doxorubicin—Decreased appetite—Pregabalin—epilepsy syndrome	1.23e-05	7.63e-05	CcSEcCtD
Doxorubicin—Agitation—Topiramate—epilepsy syndrome	1.23e-05	7.63e-05	CcSEcCtD
Doxorubicin—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	1.22e-05	7.58e-05	CcSEcCtD
Doxorubicin—Fatigue—Pregabalin—epilepsy syndrome	1.22e-05	7.57e-05	CcSEcCtD
Doxorubicin—Hypotension—Gabapentin—epilepsy syndrome	1.21e-05	7.52e-05	CcSEcCtD
Doxorubicin—Nausea—Carbamazepine—epilepsy syndrome	1.21e-05	7.51e-05	CcSEcCtD
Doxorubicin—Constipation—Pregabalin—epilepsy syndrome	1.21e-05	7.51e-05	CcSEcCtD
Doxorubicin—Pain—Pregabalin—epilepsy syndrome	1.21e-05	7.51e-05	CcSEcCtD
Doxorubicin—Malaise—Topiramate—epilepsy syndrome	1.2e-05	7.48e-05	CcSEcCtD
Doxorubicin—Vertigo—Topiramate—epilepsy syndrome	1.2e-05	7.46e-05	CcSEcCtD
Doxorubicin—Syncope—Topiramate—epilepsy syndrome	1.2e-05	7.44e-05	CcSEcCtD
Doxorubicin—Leukopenia—Topiramate—epilepsy syndrome	1.19e-05	7.43e-05	CcSEcCtD
Doxorubicin—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	1.18e-05	7.33e-05	CcSEcCtD
Doxorubicin—Palpitations—Topiramate—epilepsy syndrome	1.18e-05	7.33e-05	CcSEcCtD
Doxorubicin—Loss of consciousness—Topiramate—epilepsy syndrome	1.17e-05	7.29e-05	CcSEcCtD
Doxorubicin—Insomnia—Gabapentin—epilepsy syndrome	1.17e-05	7.28e-05	CcSEcCtD
Doxorubicin—Nausea—Lamotrigine—epilepsy syndrome	1.17e-05	7.26e-05	CcSEcCtD
Doxorubicin—Cough—Topiramate—epilepsy syndrome	1.16e-05	7.24e-05	CcSEcCtD
Doxorubicin—Feeling abnormal—Pregabalin—epilepsy syndrome	1.16e-05	7.23e-05	CcSEcCtD
Doxorubicin—Paraesthesia—Gabapentin—epilepsy syndrome	1.16e-05	7.23e-05	CcSEcCtD
Doxorubicin—Convulsion—Topiramate—epilepsy syndrome	1.16e-05	7.19e-05	CcSEcCtD
Doxorubicin—Gastrointestinal pain—Pregabalin—epilepsy syndrome	1.15e-05	7.18e-05	CcSEcCtD
Doxorubicin—Dyspnoea—Gabapentin—epilepsy syndrome	1.15e-05	7.18e-05	CcSEcCtD
Doxorubicin—Hypertension—Topiramate—epilepsy syndrome	1.15e-05	7.17e-05	CcSEcCtD
Doxorubicin—Somnolence—Gabapentin—epilepsy syndrome	1.15e-05	7.16e-05	CcSEcCtD
Doxorubicin—Hypersensitivity—Valproic Acid—epilepsy syndrome	1.15e-05	7.15e-05	CcSEcCtD
Doxorubicin—Dyspepsia—Gabapentin—epilepsy syndrome	1.14e-05	7.09e-05	CcSEcCtD
Doxorubicin—Arthralgia—Topiramate—epilepsy syndrome	1.14e-05	7.07e-05	CcSEcCtD
Doxorubicin—Chest pain—Topiramate—epilepsy syndrome	1.14e-05	7.07e-05	CcSEcCtD
Doxorubicin—Myalgia—Topiramate—epilepsy syndrome	1.14e-05	7.07e-05	CcSEcCtD
Doxorubicin—Anxiety—Topiramate—epilepsy syndrome	1.13e-05	7.04e-05	CcSEcCtD
Doxorubicin—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	1.13e-05	7.02e-05	CcSEcCtD
Doxorubicin—Decreased appetite—Gabapentin—epilepsy syndrome	1.12e-05	7e-05	CcSEcCtD
Doxorubicin—Discomfort—Topiramate—epilepsy syndrome	1.12e-05	6.98e-05	CcSEcCtD
Doxorubicin—Urticaria—Pregabalin—epilepsy syndrome	1.12e-05	6.97e-05	CcSEcCtD
Doxorubicin—Asthenia—Valproic Acid—epilepsy syndrome	1.12e-05	6.97e-05	CcSEcCtD
Doxorubicin—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	1.12e-05	6.95e-05	CcSEcCtD
Doxorubicin—Fatigue—Gabapentin—epilepsy syndrome	1.12e-05	6.94e-05	CcSEcCtD
Doxorubicin—Abdominal pain—Pregabalin—epilepsy syndrome	1.12e-05	6.94e-05	CcSEcCtD
Doxorubicin—Body temperature increased—Pregabalin—epilepsy syndrome	1.12e-05	6.94e-05	CcSEcCtD
Doxorubicin—Dry mouth—Topiramate—epilepsy syndrome	1.11e-05	6.91e-05	CcSEcCtD
Doxorubicin—Pain—Gabapentin—epilepsy syndrome	1.11e-05	6.88e-05	CcSEcCtD
Doxorubicin—Constipation—Gabapentin—epilepsy syndrome	1.11e-05	6.88e-05	CcSEcCtD
Doxorubicin—Pruritus—Valproic Acid—epilepsy syndrome	1.1e-05	6.87e-05	CcSEcCtD
Doxorubicin—Confusional state—Topiramate—epilepsy syndrome	1.1e-05	6.83e-05	CcSEcCtD
Doxorubicin—Oedema—Topiramate—epilepsy syndrome	1.09e-05	6.77e-05	CcSEcCtD
Doxorubicin—Infection—Topiramate—epilepsy syndrome	1.08e-05	6.73e-05	CcSEcCtD
Doxorubicin—Shock—Topiramate—epilepsy syndrome	1.07e-05	6.66e-05	CcSEcCtD
Doxorubicin—Diarrhoea—Valproic Acid—epilepsy syndrome	1.07e-05	6.64e-05	CcSEcCtD
Doxorubicin—Nervous system disorder—Topiramate—epilepsy syndrome	1.07e-05	6.64e-05	CcSEcCtD
Doxorubicin—Feeling abnormal—Gabapentin—epilepsy syndrome	1.07e-05	6.63e-05	CcSEcCtD
Doxorubicin—Thrombocytopenia—Topiramate—epilepsy syndrome	1.07e-05	6.63e-05	CcSEcCtD
Doxorubicin—Tachycardia—Topiramate—epilepsy syndrome	1.06e-05	6.61e-05	CcSEcCtD
Doxorubicin—Gastrointestinal pain—Gabapentin—epilepsy syndrome	1.06e-05	6.58e-05	CcSEcCtD
Doxorubicin—Skin disorder—Topiramate—epilepsy syndrome	1.06e-05	6.58e-05	CcSEcCtD
Doxorubicin—Hyperhidrosis—Topiramate—epilepsy syndrome	1.05e-05	6.55e-05	CcSEcCtD
Doxorubicin—Hypersensitivity—Pregabalin—epilepsy syndrome	1.04e-05	6.47e-05	CcSEcCtD
Doxorubicin—Anorexia—Topiramate—epilepsy syndrome	1.04e-05	6.46e-05	CcSEcCtD
Doxorubicin—Dizziness—Valproic Acid—epilepsy syndrome	1.03e-05	6.42e-05	CcSEcCtD
Doxorubicin—Urticaria—Gabapentin—epilepsy syndrome	1.03e-05	6.4e-05	CcSEcCtD
Doxorubicin—Body temperature increased—Gabapentin—epilepsy syndrome	1.02e-05	6.36e-05	CcSEcCtD
Doxorubicin—Abdominal pain—Gabapentin—epilepsy syndrome	1.02e-05	6.36e-05	CcSEcCtD
Doxorubicin—Hypotension—Topiramate—epilepsy syndrome	1.02e-05	6.33e-05	CcSEcCtD
Doxorubicin—Asthenia—Pregabalin—epilepsy syndrome	1.01e-05	6.3e-05	CcSEcCtD
Doxorubicin—Pruritus—Pregabalin—epilepsy syndrome	9.98e-06	6.21e-05	CcSEcCtD
Doxorubicin—Vomiting—Valproic Acid—epilepsy syndrome	9.92e-06	6.17e-05	CcSEcCtD
Doxorubicin—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	9.92e-06	6.17e-05	CcSEcCtD
Doxorubicin—Insomnia—Topiramate—epilepsy syndrome	9.84e-06	6.13e-05	CcSEcCtD
Doxorubicin—Rash—Valproic Acid—epilepsy syndrome	9.84e-06	6.12e-05	CcSEcCtD
Doxorubicin—Dermatitis—Valproic Acid—epilepsy syndrome	9.83e-06	6.12e-05	CcSEcCtD
Doxorubicin—Headache—Valproic Acid—epilepsy syndrome	9.78e-06	6.08e-05	CcSEcCtD
Doxorubicin—Paraesthesia—Topiramate—epilepsy syndrome	9.77e-06	6.08e-05	CcSEcCtD
Doxorubicin—Dyspnoea—Topiramate—epilepsy syndrome	9.7e-06	6.04e-05	CcSEcCtD
Doxorubicin—Somnolence—Topiramate—epilepsy syndrome	9.68e-06	6.02e-05	CcSEcCtD
Doxorubicin—Diarrhoea—Pregabalin—epilepsy syndrome	9.65e-06	6.01e-05	CcSEcCtD
Doxorubicin—Dyspepsia—Topiramate—epilepsy syndrome	9.58e-06	5.96e-05	CcSEcCtD
Doxorubicin—Hypersensitivity—Gabapentin—epilepsy syndrome	9.53e-06	5.93e-05	CcSEcCtD
Doxorubicin—Decreased appetite—Topiramate—epilepsy syndrome	9.46e-06	5.89e-05	CcSEcCtD
Doxorubicin—Gastrointestinal disorder—Topiramate—epilepsy syndrome	9.4e-06	5.85e-05	CcSEcCtD
Doxorubicin—Fatigue—Topiramate—epilepsy syndrome	9.38e-06	5.84e-05	CcSEcCtD
Doxorubicin—Dizziness—Pregabalin—epilepsy syndrome	9.33e-06	5.81e-05	CcSEcCtD
Doxorubicin—Pain—Topiramate—epilepsy syndrome	9.31e-06	5.79e-05	CcSEcCtD
Doxorubicin—Constipation—Topiramate—epilepsy syndrome	9.31e-06	5.79e-05	CcSEcCtD
Doxorubicin—Asthenia—Gabapentin—epilepsy syndrome	9.28e-06	5.78e-05	CcSEcCtD
Doxorubicin—Nausea—Valproic Acid—epilepsy syndrome	9.27e-06	5.77e-05	CcSEcCtD
Doxorubicin—Pruritus—Gabapentin—epilepsy syndrome	9.15e-06	5.7e-05	CcSEcCtD
Doxorubicin—Vomiting—Pregabalin—epilepsy syndrome	8.97e-06	5.58e-05	CcSEcCtD
Doxorubicin—Feeling abnormal—Topiramate—epilepsy syndrome	8.97e-06	5.58e-05	CcSEcCtD
Doxorubicin—Gastrointestinal pain—Topiramate—epilepsy syndrome	8.9e-06	5.54e-05	CcSEcCtD
Doxorubicin—Rash—Pregabalin—epilepsy syndrome	8.9e-06	5.54e-05	CcSEcCtD
Doxorubicin—Dermatitis—Pregabalin—epilepsy syndrome	8.89e-06	5.53e-05	CcSEcCtD
Doxorubicin—Diarrhoea—Gabapentin—epilepsy syndrome	8.85e-06	5.51e-05	CcSEcCtD
Doxorubicin—Headache—Pregabalin—epilepsy syndrome	8.84e-06	5.5e-05	CcSEcCtD
Doxorubicin—Urticaria—Topiramate—epilepsy syndrome	8.65e-06	5.38e-05	CcSEcCtD
Doxorubicin—Body temperature increased—Topiramate—epilepsy syndrome	8.6e-06	5.35e-05	CcSEcCtD
Doxorubicin—Abdominal pain—Topiramate—epilepsy syndrome	8.6e-06	5.35e-05	CcSEcCtD
Doxorubicin—Dizziness—Gabapentin—epilepsy syndrome	8.56e-06	5.32e-05	CcSEcCtD
Doxorubicin—Nausea—Pregabalin—epilepsy syndrome	8.38e-06	5.21e-05	CcSEcCtD
Doxorubicin—Vomiting—Gabapentin—epilepsy syndrome	8.23e-06	5.12e-05	CcSEcCtD
Doxorubicin—Rash—Gabapentin—epilepsy syndrome	8.16e-06	5.08e-05	CcSEcCtD
Doxorubicin—Dermatitis—Gabapentin—epilepsy syndrome	8.15e-06	5.07e-05	CcSEcCtD
Doxorubicin—Headache—Gabapentin—epilepsy syndrome	8.1e-06	5.04e-05	CcSEcCtD
Doxorubicin—Hypersensitivity—Topiramate—epilepsy syndrome	8.02e-06	4.99e-05	CcSEcCtD
Doxorubicin—Asthenia—Topiramate—epilepsy syndrome	7.81e-06	4.86e-05	CcSEcCtD
Doxorubicin—Pruritus—Topiramate—epilepsy syndrome	7.7e-06	4.79e-05	CcSEcCtD
Doxorubicin—Nausea—Gabapentin—epilepsy syndrome	7.68e-06	4.78e-05	CcSEcCtD
Doxorubicin—Diarrhoea—Topiramate—epilepsy syndrome	7.45e-06	4.63e-05	CcSEcCtD
Doxorubicin—Dizziness—Topiramate—epilepsy syndrome	7.2e-06	4.48e-05	CcSEcCtD
Doxorubicin—Vomiting—Topiramate—epilepsy syndrome	6.92e-06	4.31e-05	CcSEcCtD
Doxorubicin—Rash—Topiramate—epilepsy syndrome	6.86e-06	4.27e-05	CcSEcCtD
Doxorubicin—Dermatitis—Topiramate—epilepsy syndrome	6.86e-06	4.27e-05	CcSEcCtD
Doxorubicin—Headache—Topiramate—epilepsy syndrome	6.82e-06	4.24e-05	CcSEcCtD
Doxorubicin—Nausea—Topiramate—epilepsy syndrome	6.47e-06	4.02e-05	CcSEcCtD
Doxorubicin—CYP1B1—Metabolism—PLCB1—epilepsy syndrome	2.01e-06	2.19e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—ST3GAL3—epilepsy syndrome	2.01e-06	2.18e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—TH—epilepsy syndrome	2.01e-06	2.18e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—CCR5—epilepsy syndrome	2e-06	2.18e-05	CbGpPWpGaD
Doxorubicin—NDUFS2—Metabolism—AKT1—epilepsy syndrome	1.99e-06	2.16e-05	CbGpPWpGaD
Doxorubicin—NOS3—Disease—FGF2—epilepsy syndrome	1.98e-06	2.15e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	1.98e-06	2.15e-05	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—GPX1—epilepsy syndrome	1.97e-06	2.15e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—ADSL—epilepsy syndrome	1.97e-06	2.14e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—CA4—epilepsy syndrome	1.96e-06	2.13e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—QDPR—epilepsy syndrome	1.96e-06	2.13e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—HTR2A—epilepsy syndrome	1.96e-06	2.13e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Biological oxidations—POMC—epilepsy syndrome	1.96e-06	2.13e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Transmembrane transport of small molecules—ALB—epilepsy syndrome	1.95e-06	2.13e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—ADRA2A—epilepsy syndrome	1.95e-06	2.12e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—BCHE—epilepsy syndrome	1.94e-06	2.11e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—HES1—epilepsy syndrome	1.94e-06	2.11e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—CACNA1A—epilepsy syndrome	1.93e-06	2.1e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—ALDH7A1—epilepsy syndrome	1.93e-06	2.1e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—GLUL—epilepsy syndrome	1.93e-06	2.1e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—CACNA1D—epilepsy syndrome	1.89e-06	2.06e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—ST3GAL3—epilepsy syndrome	1.89e-06	2.06e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—FYN—epilepsy syndrome	1.88e-06	2.05e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—epilepsy syndrome	1.88e-06	2.05e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—H2AFX—epilepsy syndrome	1.88e-06	2.04e-05	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—ALB—epilepsy syndrome	1.88e-06	2.04e-05	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—POMC—epilepsy syndrome	1.87e-06	2.04e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—TSC2—epilepsy syndrome	1.86e-06	2.03e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—AGT—epilepsy syndrome	1.86e-06	2.02e-05	CbGpPWpGaD
Doxorubicin—NOS2—Disease—SRC—epilepsy syndrome	1.86e-06	2.02e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—ADSL—epilepsy syndrome	1.85e-06	2.02e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—SLC2A1—epilepsy syndrome	1.85e-06	2.02e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—POMC—epilepsy syndrome	1.85e-06	2.01e-05	CbGpPWpGaD
Doxorubicin—NOS3—Hemostasis—AKT1—epilepsy syndrome	1.85e-06	2.01e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—COX3—epilepsy syndrome	1.84e-06	2.01e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—epilepsy syndrome	1.83e-06	1.99e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—PLCB1—epilepsy syndrome	1.83e-06	1.99e-05	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—PTGS2—epilepsy syndrome	1.83e-06	1.99e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—TH—epilepsy syndrome	1.83e-06	1.99e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—APOE—epilepsy syndrome	1.82e-06	1.98e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—GLUL—epilepsy syndrome	1.82e-06	1.98e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—CCL2—epilepsy syndrome	1.81e-06	1.97e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—YWHAZ—epilepsy syndrome	1.81e-06	1.97e-05	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—AGT—epilepsy syndrome	1.8e-06	1.96e-05	CbGpPWpGaD
Doxorubicin—NOS3—Disease—MTOR—epilepsy syndrome	1.8e-06	1.96e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—KDR—epilepsy syndrome	1.79e-06	1.94e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—CACNA1D—epilepsy syndrome	1.78e-06	1.94e-05	CbGpPWpGaD
Doxorubicin—NOS3—Disease—PTGS2—epilepsy syndrome	1.78e-06	1.94e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—TXNRD1—epilepsy syndrome	1.77e-06	1.93e-05	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—APOE—epilepsy syndrome	1.77e-06	1.92e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—PTGS2—epilepsy syndrome	1.77e-06	1.92e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	1.76e-06	1.91e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—PFKL—epilepsy syndrome	1.75e-06	1.9e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—CACNA2D2—epilepsy syndrome	1.75e-06	1.9e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—KCNB1—epilepsy syndrome	1.75e-06	1.9e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—SLCO1A2—epilepsy syndrome	1.75e-06	1.9e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—SLC6A8—epilepsy syndrome	1.75e-06	1.9e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Transmembrane transport of small molecules—AVP—epilepsy syndrome	1.74e-06	1.9e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—CCR5—epilepsy syndrome	1.74e-06	1.9e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—HMOX1—epilepsy syndrome	1.73e-06	1.88e-05	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—AGT—epilepsy syndrome	1.73e-06	1.88e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—AQP1—epilepsy syndrome	1.72e-06	1.87e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—PRKCB—epilepsy syndrome	1.72e-06	1.87e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—ABCG2—epilepsy syndrome	1.72e-06	1.87e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—IL6ST—epilepsy syndrome	1.71e-06	1.86e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—CAT—epilepsy syndrome	1.71e-06	1.86e-05	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—ALB—epilepsy syndrome	1.71e-06	1.86e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—SRC—epilepsy syndrome	1.71e-06	1.86e-05	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—APOE—epilepsy syndrome	1.69e-06	1.84e-05	CbGpPWpGaD
Doxorubicin—DHCR7—Metabolism—AKT1—epilepsy syndrome	1.69e-06	1.84e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—HMOX1—epilepsy syndrome	1.68e-06	1.82e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—CYP2C19—epilepsy syndrome	1.67e-06	1.82e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—TXNRD1—epilepsy syndrome	1.67e-06	1.81e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—CYP11A1—epilepsy syndrome	1.66e-06	1.81e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—ABCB1—epilepsy syndrome	1.66e-06	1.81e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—CAT—epilepsy syndrome	1.65e-06	1.8e-05	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—PTGS2—epilepsy syndrome	1.64e-06	1.79e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—FGF2—epilepsy syndrome	1.64e-06	1.78e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—TSC2—epilepsy syndrome	1.62e-06	1.76e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—AQP1—epilepsy syndrome	1.62e-06	1.76e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—ABCB1—epilepsy syndrome	1.61e-06	1.75e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—UPB1—epilepsy syndrome	1.6e-06	1.74e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—NEU1—epilepsy syndrome	1.6e-06	1.74e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—ATIC—epilepsy syndrome	1.6e-06	1.74e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—APOE—epilepsy syndrome	1.59e-06	1.72e-05	CbGpPWpGaD
Doxorubicin—CBR1—Metabolism—AKT1—epilepsy syndrome	1.58e-06	1.72e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—epilepsy syndrome	1.57e-06	1.71e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—POMC—epilepsy syndrome	1.57e-06	1.7e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—KCNJ11—epilepsy syndrome	1.55e-06	1.69e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—CHRM3—epilepsy syndrome	1.55e-06	1.69e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—GPX1—epilepsy syndrome	1.55e-06	1.68e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—HSD17B4—epilepsy syndrome	1.54e-06	1.67e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—CCL2—epilepsy syndrome	1.53e-06	1.67e-05	CbGpPWpGaD
Doxorubicin—NOS1—Disease—AKT1—epilepsy syndrome	1.53e-06	1.66e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—HMOX1—epilepsy syndrome	1.52e-06	1.66e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—RELA—epilepsy syndrome	1.52e-06	1.65e-05	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—POMC—epilepsy syndrome	1.52e-06	1.65e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—CAT—epilepsy syndrome	1.5e-06	1.64e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—CYP2D6—epilepsy syndrome	1.5e-06	1.63e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—GPX1—epilepsy syndrome	1.49e-06	1.63e-05	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—PTGS2—epilepsy syndrome	1.49e-06	1.62e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—MTOR—epilepsy syndrome	1.49e-06	1.62e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—IL6ST—epilepsy syndrome	1.49e-06	1.62e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—GBE1—epilepsy syndrome	1.49e-06	1.62e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—PPP1R3C—epilepsy syndrome	1.49e-06	1.62e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—NOS2—epilepsy syndrome	1.48e-06	1.61e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—KCNJ11—epilepsy syndrome	1.47e-06	1.59e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—CHRM3—epilepsy syndrome	1.47e-06	1.59e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—ABCB1—epilepsy syndrome	1.46e-06	1.59e-05	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—POMC—epilepsy syndrome	1.46e-06	1.58e-05	CbGpPWpGaD
Doxorubicin—NOS3—Disease—SRC—epilepsy syndrome	1.44e-06	1.57e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—ADRA2A—epilepsy syndrome	1.43e-06	1.56e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—BCHE—epilepsy syndrome	1.42e-06	1.55e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—ASAH1—epilepsy syndrome	1.4e-06	1.52e-05	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—ALB—epilepsy syndrome	1.38e-06	1.51e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—FGF2—epilepsy syndrome	1.38e-06	1.51e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—CASP3—epilepsy syndrome	1.37e-06	1.49e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—GPX1—epilepsy syndrome	1.36e-06	1.48e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—STXBP1—epilepsy syndrome	1.36e-06	1.48e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—SLC2A1—epilepsy syndrome	1.36e-06	1.48e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—AGT—epilepsy syndrome	1.36e-06	1.47e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—PLCB1—epilepsy syndrome	1.34e-06	1.46e-05	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—AKT1—epilepsy syndrome	1.34e-06	1.46e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—TH—epilepsy syndrome	1.34e-06	1.46e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—JUN—epilepsy syndrome	1.33e-06	1.45e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—APOE—epilepsy syndrome	1.33e-06	1.44e-05	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—ALB—epilepsy syndrome	1.33e-06	1.44e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—NT5E—epilepsy syndrome	1.32e-06	1.44e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—ALAD—epilepsy syndrome	1.32e-06	1.44e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—AGT—epilepsy syndrome	1.31e-06	1.43e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—MMP9—epilepsy syndrome	1.3e-06	1.41e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—RELA—epilepsy syndrome	1.29e-06	1.4e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—APOE—epilepsy syndrome	1.28e-06	1.4e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—ABCG2—epilepsy syndrome	1.27e-06	1.38e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—ALDH7A1—epilepsy syndrome	1.26e-06	1.37e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—CACNA1A—epilepsy syndrome	1.26e-06	1.37e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—MTOR—epilepsy syndrome	1.26e-06	1.37e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—ST3GAL3—epilepsy syndrome	1.24e-06	1.35e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—CYP2C19—epilepsy syndrome	1.24e-06	1.34e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—CYP11A1—epilepsy syndrome	1.23e-06	1.33e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—ADSL—epilepsy syndrome	1.21e-06	1.32e-05	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—PTGS2—epilepsy syndrome	1.21e-06	1.32e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—FGF2—epilepsy syndrome	1.2e-06	1.31e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—SRC—epilepsy syndrome	1.2e-06	1.3e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—ABCG2—epilepsy syndrome	1.19e-06	1.3e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—AGT—epilepsy syndrome	1.19e-06	1.3e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—GLUL—epilepsy syndrome	1.19e-06	1.29e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—epilepsy syndrome	1.17e-06	1.27e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—APOE—epilepsy syndrome	1.17e-06	1.27e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—CACNA1D—epilepsy syndrome	1.17e-06	1.27e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—VEGFA—epilepsy syndrome	1.16e-06	1.27e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—CYP2C19—epilepsy syndrome	1.16e-06	1.27e-05	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—PTGS2—epilepsy syndrome	1.16e-06	1.26e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—CASP3—epilepsy syndrome	1.16e-06	1.26e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—CYP11A1—epilepsy syndrome	1.16e-06	1.26e-05	CbGpPWpGaD
Doxorubicin—NOS2—Disease—AKT1—epilepsy syndrome	1.15e-06	1.26e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—POMC—epilepsy syndrome	1.14e-06	1.24e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—JUN—epilepsy syndrome	1.13e-06	1.22e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—HMOX1—epilepsy syndrome	1.12e-06	1.22e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—CYP2D6—epilepsy syndrome	1.11e-06	1.2e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—POMC—epilepsy syndrome	1.1e-06	1.2e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—CAT—epilepsy syndrome	1.1e-06	1.2e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—MTOR—epilepsy syndrome	1.1e-06	1.19e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—MMP9—epilepsy syndrome	1.1e-06	1.19e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	1.09e-06	1.19e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—PTGS2—epilepsy syndrome	1.09e-06	1.18e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—ABCB1—epilepsy syndrome	1.07e-06	1.17e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—AKT1—epilepsy syndrome	1.06e-06	1.15e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—AQP1—epilepsy syndrome	1.06e-06	1.15e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Transmembrane transport of small molecules—ALB—epilepsy syndrome	1.06e-06	1.15e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—ADRA2A—epilepsy syndrome	1.05e-06	1.15e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—BCHE—epilepsy syndrome	1.05e-06	1.14e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—ALB—epilepsy syndrome	1.04e-06	1.13e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—SRC—epilepsy syndrome	1.01e-06	1.1e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—ALB—epilepsy syndrome	1.01e-06	1.09e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—POMC—epilepsy syndrome	1e-06	1.09e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—SLC2A1—epilepsy syndrome	1e-06	1.09e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—GPX1—epilepsy syndrome	9.97e-07	1.08e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—ADRA2A—epilepsy syndrome	9.94e-07	1.08e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—PLCB1—epilepsy syndrome	9.91e-07	1.08e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—BCHE—epilepsy syndrome	9.9e-07	1.08e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—TH—epilepsy syndrome	9.87e-07	1.07e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—VEGFA—epilepsy syndrome	9.84e-07	1.07e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	9.58e-07	1.04e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	9.58e-07	1.04e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—SLC2A1—epilepsy syndrome	9.44e-07	1.03e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—PLCB1—epilepsy syndrome	9.34e-07	1.02e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—TH—epilepsy syndrome	9.3e-07	1.01e-05	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—AKT1—epilepsy syndrome	9.21e-07	1e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—ALB—epilepsy syndrome	9.15e-07	9.95e-06	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—PTGS2—epilepsy syndrome	9.1e-07	9.9e-06	CbGpPWpGaD
Doxorubicin—NOS3—Disease—AKT1—epilepsy syndrome	8.96e-07	9.75e-06	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—AKT1—epilepsy syndrome	8.88e-07	9.66e-06	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—PTGS2—epilepsy syndrome	8.8e-07	9.57e-06	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—SRC—epilepsy syndrome	8.79e-07	9.56e-06	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—AGT—epilepsy syndrome	8.74e-07	9.51e-06	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—APOE—epilepsy syndrome	8.57e-07	9.32e-06	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—AKT1—epilepsy syndrome	8.26e-07	8.98e-06	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—HMOX1—epilepsy syndrome	8.24e-07	8.96e-06	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—CAT—epilepsy syndrome	8.13e-07	8.84e-06	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—PTGS2—epilepsy syndrome	8.01e-07	8.71e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	7.81e-07	8.49e-06	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—HMOX1—epilepsy syndrome	7.77e-07	8.45e-06	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—CAT—epilepsy syndrome	7.66e-07	8.33e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	7.61e-07	8.28e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	7.56e-07	8.22e-06	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—AKT1—epilepsy syndrome	7.5e-07	8.16e-06	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—ABCB1—epilepsy syndrome	7.45e-07	8.11e-06	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—AKT1—epilepsy syndrome	7.43e-07	8.08e-06	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—POMC—epilepsy syndrome	7.36e-07	8e-06	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—GPX1—epilepsy syndrome	7.35e-07	8e-06	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—GPX1—epilepsy syndrome	6.93e-07	7.54e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	6.83e-07	7.42e-06	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—ALB—epilepsy syndrome	6.71e-07	7.3e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	6.5e-07	7.07e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—BCHE—epilepsy syndrome	6.47e-07	7.04e-06	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—AGT—epilepsy syndrome	6.45e-07	7.01e-06	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—APOE—epilepsy syndrome	6.32e-07	6.87e-06	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—AKT1—epilepsy syndrome	6.28e-07	6.83e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	6.17e-07	6.71e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	6.11e-07	6.64e-06	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—AKT1—epilepsy syndrome	6.09e-07	6.62e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—TH—epilepsy syndrome	6.08e-07	6.62e-06	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—AGT—epilepsy syndrome	6.08e-07	6.61e-06	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—APOE—epilepsy syndrome	5.95e-07	6.47e-06	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—PTGS2—epilepsy syndrome	5.87e-07	6.38e-06	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—AKT1—epilepsy syndrome	5.84e-07	6.35e-06	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—AKT1—epilepsy syndrome	5.46e-07	5.94e-06	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—POMC—epilepsy syndrome	5.43e-07	5.9e-06	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—POMC—epilepsy syndrome	5.11e-07	5.56e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	5.08e-07	5.52e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—CAT—epilepsy syndrome	5.01e-07	5.45e-06	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—ALB—epilepsy syndrome	4.95e-07	5.38e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	4.87e-07	5.3e-06	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—ALB—epilepsy syndrome	4.66e-07	5.07e-06	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—AKT1—epilepsy syndrome	4.57e-07	4.97e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—GPX1—epilepsy syndrome	4.53e-07	4.93e-06	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—AKT1—epilepsy syndrome	4.42e-07	4.81e-06	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—PTGS2—epilepsy syndrome	4.33e-07	4.71e-06	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—PTGS2—epilepsy syndrome	4.08e-07	4.44e-06	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—AKT1—epilepsy syndrome	4.02e-07	4.38e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—AGT—epilepsy syndrome	3.97e-07	4.32e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—APOE—epilepsy syndrome	3.89e-07	4.23e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—POMC—epilepsy syndrome	3.34e-07	3.64e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—ALB—epilepsy syndrome	3.05e-07	3.32e-06	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—AKT1—epilepsy syndrome	2.95e-07	3.21e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	2.67e-07	2.9e-06	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—AKT1—epilepsy syndrome	2.18e-07	2.37e-06	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—AKT1—epilepsy syndrome	2.05e-07	2.23e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—AKT1—epilepsy syndrome	1.34e-07	1.46e-06	CbGpPWpGaD
